Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis.

Dimitroulas T, Sandoo A, Smith JP, Kitas GD.

Int J Cardiol. 2014 Mar 1;172(1):285-6. doi: 10.1016/j.ijcard.2013.12.235. Epub 2014 Jan 10. No abstract available.

PMID:
24447745
[PubMed - in process]
2.

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.

Sandoo A, Dimitroulas T, Toms TE, Hodson J, Veldhuijzen van Zanten JJ, Smith JP, Kitas GD.

Clin Biochem. 2012 Nov;45(16-17):1399-403. doi: 10.1016/j.clinbiochem.2012.07.092. Epub 2012 Jul 20.

PMID:
22820438
[PubMed - indexed for MEDLINE]
3.

Plasma asymmetric dimethylarginine in active rheumatoid arthritis: links with oxidative stress and inflammation.

Kwaśny-Krochin B, Głuszko P, Undas A.

Pol Arch Med Wewn. 2012;122(6):270-6. Epub 2012 Apr 30.

PMID:
22549098
[PubMed - indexed for MEDLINE]
Free Article
4.

Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance.

Dimitroulas T, Sandoo A, Veldhuijzen van Zanten JJ, Smith JP, Hodson J, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD.

Scand J Rheumatol. 2013;42(3):176-81. doi: 10.3109/03009742.2012.747627. Epub 2013 Jan 14.

PMID:
23311682
[PubMed - indexed for MEDLINE]
5.

The L-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness.

Angel K, Provan SA, Mowinckel P, Seljeflot I, Kvien TK, Atar D.

Atherosclerosis. 2012 Nov;225(1):160-5. doi: 10.1016/j.atherosclerosis.2012.08.033. Epub 2012 Sep 10.

PMID:
23014354
[PubMed - indexed for MEDLINE]
6.

Lack of association between asymmetric dimethylarginine and in vivo microvascular and macrovascular endothelial function in patients with rheumatoid arthritis.

Sandoo A, Dimitroulas T, Veldhuijzen van Zanten JJ, Smith JP, Metsios GS, Nightingale P, Stavropoulos-Kalinoglou A, Kitas GD.

Clin Exp Rheumatol. 2012 May-Jun;30(3):388-96. Epub 2012 Jun 26.

PMID:
22410121
[PubMed - indexed for MEDLINE]
7.

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?

Anderson JL, Carlquist JF, Roberts WL, Horne BD, May HT, Schwarz EL, Pasquali M, Nielson R, Kushnir MM, Rockwood AL, Bair TL, Muhlestein JB; Intermountain Heart Collaborative Study Group.

Am Heart J. 2007 Jan;153(1):67-73.

PMID:
17174641
[PubMed - indexed for MEDLINE]
8.

Heart rate, ejection duration and subendocardial viability ratio in patients with rheumatoid arthritis as compared to controls.

Pieringer H, Brummaier T, Schmid M, Pichler M, Hayat-Khayyati A, Ebner S, Biesenbach G, Pohanka E.

Int J Rheum Dis. 2014 Jan;17(1):39-43. doi: 10.1111/1756-185X.12046. Epub 2013 Jan 24.

PMID:
24472265
[PubMed - in process]
9.

Determination of the diagnostic values of asymmetric dimethylarginine as an indicator for evaluation of the endothelial dysfunction in patients with rheumatoid arthritis.

Spasovski D, Latifi A, Osmani B, Krstevska-Balkanov S, Kafedizska I, Slaninka-Micevska M, Dejanova B, Alabakovska S, Balkanov T.

Arthritis. 2013;2013:818037. doi: 10.1155/2013/818037. Epub 2013 May 15.

PMID:
23762554
[PubMed]
Free PMC Article
10.

Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.

Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, Schulze F, Xanthakis V, Benndorf RA, Vasan RS.

Circulation. 2009 Mar 31;119(12):1592-600. doi: 10.1161/CIRCULATIONAHA.108.838268. Epub 2009 Mar 16.

PMID:
19289633
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Asymmetric dimethylarginine plasma concentrations and L-arginine/asymmetric dimethylarginine ratio in patients with slow coronary flow.

Selcuk MT, Selcuk H, Temizhan A, Maden O, Ulupinar H, Baysal E, Ozeke O, Sasmaz A.

Coron Artery Dis. 2007 Nov;18(7):545-51.

PMID:
17925608
[PubMed - indexed for MEDLINE]
12.

Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration.

Surdacki A, Martens-Lobenhoffer J, Wloch A, Gluszko P, Rakowski T, Dubiel JS, Bode-Böger SM.

Metabolism. 2009 Mar;58(3):316-8. doi: 10.1016/j.metabol.2008.10.002.

PMID:
19217445
[PubMed - indexed for MEDLINE]
13.

Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters.

Kemény-Beke Á, Gesztelyi R, Bodnár N, Zsuga J, Kerekes G, Zsuga M, Biri B, Kéki S, Szodoray P, Berta A, Szekanecz Z, Szántó S.

Joint Bone Spine. 2011 Mar;78(2):184-7. doi: 10.1016/j.jbspin.2010.05.009.

PMID:
20620092
[PubMed - indexed for MEDLINE]
14.

Involvement of DDAH/ADMA pathway in the pathogenesis of rheumatoid arthritis in rats.

Chen XM, Xia J, Zhou T, Yuan Q, Zhang WF, Hu CP, Li YJ, Jiang JL.

Int Immunopharmacol. 2013 Jun;16(2):322-31. doi: 10.1016/j.intimp.2013.04.009. Epub 2013 Apr 22.

PMID:
23619555
[PubMed - indexed for MEDLINE]
15.

Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.

Turiel M, Atzeni F, Tomasoni L, de Portu S, Delfino L, Bodini BD, Longhi M, Sitia S, Bianchi M, Ferrario P, Doria A, De Gennaro Colonna V, Sarzi-Puttini P.

Rheumatology (Oxford). 2009 Jul;48(7):834-9. doi: 10.1093/rheumatology/kep082. Epub 2009 May 22.

PMID:
19465588
[PubMed - indexed for MEDLINE]
Free Article
16.

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease.

Sibal L, Agarwal SC, Home PD, Boger RH.

Curr Cardiol Rev. 2010 May;6(2):82-90. doi: 10.2174/157340310791162659.

PMID:
21532773
[PubMed]
Free PMC Article
17.

Asymmetric dimethylarginine, endothelial dysfunction and renal disease.

Aldámiz-Echevarría L, Andrade F.

Int J Mol Sci. 2012;13(9):11288-311. doi: 10.3390/ijms130911288. Epub 2012 Sep 10.

PMID:
23109853
[PubMed]
Free PMC Article
18.

Arginine/asymmetric dimethylarginine ratio and cardiovascular risk factors in patients with predialytic chronic kidney disease.

Hov GG, Sagen E, Hatlen G, Bigonah A, Åsberg A, Aasarød K.

Clin Biochem. 2011 Jun;44(8-9):642-6. doi: 10.1016/j.clinbiochem.2011.03.024. Epub 2011 Mar 21.

PMID:
21406191
[PubMed - indexed for MEDLINE]
19.

Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis.

Di Franco M, Spinelli FR, Metere A, Gerardi MC, Conti V, Boccalini F, Iannuccelli C, Ciciarello F, Agati L, Valesini G.

Mediators Inflamm. 2012;2012:347268. doi: 10.1155/2012/347268. Epub 2012 Aug 7.

PMID:
22927708
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells.

Wang J, Sim AS, Wang XL, Wilcken DE.

Cell Mol Life Sci. 2006 Dec;63(23):2838-46.

PMID:
17075694
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk